ACCME updated its Standards for Integrity and

ACCME updated its Standards for Integrity and Independence in Accredited Continuing Education in December 2020. Accordingly, ACLP's disclosure reporting rules have changed to comply. In very basic terms, the primary changes you need to know are:

You are now required to only disclosure financial relationships with "ineligible companies" (as defined by ACCME, below) and no other. If you must report, you must disclose all financial relationships of any amount; there is no minimum.
You are no longer required to disclose reporting of any kind for your spouse/partner.
The reporting period now covers the 24-month period prior to you completing your declaration.

ACLP is required to "mitigate" speaker relationships with ineligible companies and share this with attendees. ACLP must also disclose no-conflict reporting to attendees; that is, attendees must be informed of and have access to information on the CoI status of ALL speakers, not just those that have declared interests. YOUR DISCLOSURE STATEMENT This is an information slide; delete it after you have finalized your disclosure statement<br>

As defined by ACCME:
Advertising, marketing, or communication firms whose clients are ineligible companies
Bio-medical startups that have begun a governmental regulatory approval process
Compounding pharmacies that manufacture proprietary compounds
Device manufacturers or distributors
Diagnostic labs that sell proprietary products
Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
Manufacturers of health-related wearable products
Pharmaceutical companies or distributors
Pharmacy benefit managers
Reagent manufacturers or sellers

If you have a financial relationship of any kind and of any amount in respect of any of the above, you must provide three data points:

The name of the company in this relationship
The nature of the company's business
The nature of the financial relationship. Examples of financial relationships include employee, researcher, consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and ownership interest. Individual stocks and stock options should be disclosed; diversified mutual funds do not need to be disclosed. Research funding from ineligible companies should be disclosed by the principal or named investigator even if that individual's institution receives the research grant and manages the funds.

You are not obliged to disclose the amount of compensation involved in your financial relationships.

Example reporting: ABC Company, Inc; device manufacturer; patent beneficiary. WHAT IS AN INELIGIBLE COMPANY? This is an information slide; delete it after you have finalized your disclosure statement<br>

You are encouraged, but not required to use the Academy’s official design template.

Select ONE of the next two slides for your presentation.

Delete the red-lined boxes once you have decided which slide to use.

Disclosure of commercial support must never include the use of a trade name or a product-group message. Acknowledgment of commercial support may state the name, mission, and areas of clinical involvement but may not include corporate logos and slogans.

ACLP will contact you to resolve any potential conflict of interest prior to the start of your presentation.

Example reporting: ABC Company Inc; device manufacturer; patent beneficiary. Entity name Nature of business Nature of your financial relationship This is the extent of required disclosure This is an information slide; delete it after you have finalized your disclosure statement<br>